Académique Documents
Professionnel Documents
Culture Documents
PCOS)
Lenny Lisal,SpOG
Division of Reproductive Endocrinology
& Fertility
Department of Obstetrics and Gynecology
Medical Faculty Hasanuddin University
Makassar
Introduction
Irving Stein and Michael Levental, first
diagnosed PCOS
Seven women infertility and amenorrhea
Pelvic X-ray enlarged ovaries that
contained several cystic structures
Wedge resections removed obstructions
from the ovary, normal ovarian fuction
resumed!
Five of them conceived!
INTRODUCTION
The four main symptoms of PCOS, Stein
and Leventhal :
Irreguler menstruation,
Infertility,
Obesity, and
Hirsutism
PREVALENCE
About 20 % of reproductive age women
demonstrate the USG picture of PCO.
About 5-10 % have clinical of biochemichal sign
of anovulation and androgen excess.
Dunaif 1995, Norman et al 2002
Estimation of true prevalence PCOS must be
made with caution since there is on overall
consensus on the diagnostic criteria that must be
satisfied to make a diagnosis.
Ledger and Clark 2003
Criteria for diagnosis of PCOD
Major criteria
Chronic anovulation
Clinical sign of androgen excess
Hirsutism
Acne
Alopecia
Menstrual disturbance
Infertility
Virilization
Excelussion of alternative causes androgen excess
Minor criteria
Insulin resistenace
Onset at puberty
Elevated LH: FSH ratio > 2.5-3.0
Ultrasonographic evidence of plycistic ovaries
Obesity BMI > 27.5 kg/cm2
NIH-NICHD 1997
Anovulation Insulin Resistance
Hirsutism
LH/FSH >3
Obesity
Hiperandrogenemia PCO (USG)
1. Usg
2. Hormonal Examination
3. Insulin Resistance
The European Society for Human
Reproduction and Embriology (ESHRE) &
American Society for Reproductive Medicine
(ASRM)
CLINICAL SIGNS
PATHOPHYSIOLOGY
Pathophysioloy of
Polycistic Ovary Syndrome
Pituitury
LH Secration
FSH Secretion
Adipose Ovary
Tissue Chromis
Extraglandular Anovulation Impaired
Aromatization Development
Of Follicle
Obesity
Hyperandrogenism
Hirsutism
Hyperinsulinemia Acne
Insulin Resistance Alopecia
IGFBP-1
Insulin
R
(Insulin Resisten) +
Androgen
- R FSH
IGFBP-1
Hyperandrogenism Production
Aromatase
+
Estradiol R Insulin
Granolosa Cells Defective
Folicular
maturation
Insulin
resistance
Hyperinsulinaemia
Androgen Activity
Insulin resistance
Insulin
? Glucose intolerance
Liver Adrenal
Gland
Ovary
Hypertension
Sex hormone
binding
globulin
Dyslipidaemia
Androgen Activity
Ovary
?
Androgens
Ovary
Cause-and-effect
relationship
Serum insulin
Obesity
Insulin
SHBG
Free
testosterone
PCOD
Non-obese Obese
GH Insulin resistance
LH LH and IGF-I Hyperinsulinemia
effect
IGFBP-I
on theca cells
IGF-I
Cytochrome
p-450c 17-alpha activity SHBG
Androgen secretion
Long term Risk PCOS
Hypertention
Altered lipid level
Hyperinsulinemia Fibrinolysis, vasodilation
Insulin resistance Hirsutism
Hyperandrogenism Myocard infarc
Chronic an-ovulation Type 2 DM
Endometrial Cancer
Frekwency of SIGNS and
SYMPTOMS
Hirsutism
Oligomenorrhea 60 90 %
Infertility 50 90 %
55 75 %
Polycistic on USG
50 75 %
Obesity
40 60 %
Amenorrhea
26 51 %
Acne 24 27 %
DUB 29 %
Normal Menstruan pattern 22 %
Virilization 0 28 %
Pituitary
Insulin
Resitance
Insulin
Ovary
Liver
Estrogen Activin
IGF1 & IGF II
IGFBP-1 Inhibin
SHBG
Free estradiol Androgens
Adipose
Pathophysiology of polycystic ovary syndrome (FSH=Follicle stimulating hormone; IGF= insulin-like growth factor: IGFBP = insulin-
Like growth factor-binding protein; LH= luteinizing hormone; SHBG= sex hormone binding globulin)
Revised 2003 consensus on diagnostic
criteria and long-term health risks related
to plycystic ovary syndrome
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
Rotterdam, The Netherlands
TABLE 3
Criteria for the metabolic syndrome in women with
polycystic ovary syndrome. (Three of five quality for the
syndrome.)
Risk Factor Cuto off
1. Abdominal obesity (waist > 88 cm (>35 inch)
circumference)
2. Triglycerides > 150 mg/dL
3. HDL-C < 50 mg/dL
4. Blood pressure > 130/> 85
5. Fasting and 2-h glucose from 110-126 mg/dL and/or 2-h
oral glucose tolerance test glucose 140-199 mg/dL
5a-Reductase 11b-HSD1
Activity Activity
Cortisol
Metabolism
ACTH
PCOS
PATHOPHYSIOLOGY OF PCOs
(HYPOTHESIS
CENTRAL
(LH ) 55 %
I.R OVARY
69 % 64 %
HYPER
ANDROGEN*
OLIGO /
PCO
AN OVUL
PCOs 50 % Obese
Obesity Insulin Resistance
Insulin Resistance - PCOs
Insulin HYPERANDROGEN
Resistance
OBESITY - I.R - PCOs
OBESITY
LEPTIN INSULIN
-INTERNEURON
THECA FREE
(MCH,NO) IGF BP-1 SHBG
-NPY CELL IGF I&II
GnRH TESTOSTERON
ANDRO-
RATIO STENEDION
LH E1
FSH (PERIPHERY) -MUSCLE FREE FREE E2
-FAT TESTOSTERON PERIPHERY
E2 . DISTURB
INTRA . FOLICULO-
GENESIS
HIRSUTISME
FOLICEL
-DUB
-MALIGNANCY RISK
ANOVULATION -ENDOMET.(5X)
-BREAST (2X)
PCOs - INFERTILITY
PCOs
OLIGO/ AN
HYPERANDROGEN
OVULATION
INCREASED LH
ALTERED OMI
GnRH
PITUITARY
FSH QUALITY OF
OBESITY LEPTIN OOCYTE
LH
OVARY DISTURB
64% FOLICULO- OLIGO
I.R GENESIS ANOVUL.
LEAN
69%
HYPER
ESTROGEN
ANDROGEN
PERIPHERY
PCO ABORTION
-NID DM RATE
-DISLIPIDEMIA HIRSUTISM DUB
-HYPERTENSION
ENDOMETRIAL CA
-CVD BREAST CA INFERTILITY
IGF-1 ACTIVITY
THECA CELLS
LH R
R IGFBP-1
+
INSULLIN R
(INSUL.RESIST)
+ ANDROGEN
IGF-1 FROM
CIRCULATION
IGBP-1 ? R
PROD.
- FSH
HYPER + INSULLIN
ANDROGENISM AROMATASE R (INSUL.RESIST)
E2 DEFECTIVE
FOLLICULAR
GRANULOSA CELLS MATURATION